Brigit Biofarmaka Teknologi Tbk. vs Putra Rajawali Kencana Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Putra Rajawali Kencana Tbk. trades at Rp31 (market cap 195.36B, 2.73M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. and Putra Rajawali Kencana Tbk. are close in size by market cap, and Putra Rajawali Kencana Tbk. is more actively traded (2.73M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | PURA | |
|---|---|---|
Market Cap | 172.82B | 195.36B |
Volume | 592.2K | 2.73M |
Lot | 5.92K | 27.27K |
Turnover | 147.05M | 84.32M |
Average Price | 248.31 | 30.92 |
Value | 147.05M | 84.32M |
Indicative Equilibrium Price | 254 | 31 |
Indicative Equilibrium Volume | 10 | 1.44K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Putra Rajawali Kencana Tbk (the Company) was established based on notary deed No. 05 dated April 17, 2012 of Juanita Sari Dewi, SH., notary in Surabaya.
Read more on PURA →